155 related articles for article (PubMed ID: 33648780)
1. 3 Tesla serial magnetic resonance imaging of human African trypanosomiasis (Trypanosoma brucei gambiense) and review of the literature.
Boukobza M; Lariven S; Houze S; Laissy JP
Rev Neurol (Paris); 2021 Nov; 177(9):1176-1182. PubMed ID: 33648780
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study.
Büscher P; Mertens P; Leclipteux T; Gilleman Q; Jacquet D; Mumba-Ngoyi D; Pyana PP; Boelaert M; Lejon V
Lancet Glob Health; 2014 Jun; 2(6):e359-63. PubMed ID: 25103304
[TBL] [Abstract][Full Text] [Related]
3. Human African trypanosomiasis with 7-year incubation period: clinical, laboratory and neuroimaging findings.
Wengert O; Kopp M; Siebert E; Stenzel W; Hegasy G; Suttorp N; Stich A; Zoller T
Parasitol Int; 2014 Jun; 63(3):557-60. PubMed ID: 24613272
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
[TBL] [Abstract][Full Text] [Related]
5. Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study.
Kande Betu Ku Mesu V; Mutombo Kalonji W; Bardonneau C; Valverde Mordt O; Ngolo Tete D; Blesson S; Simon F; Delhomme S; Bernhard S; Mahenzi Mbembo H; Mpia Moke C; Lumeya Vuvu S; Mudji E'kitiak J; Akwaso Masa F; Mukendi Ilunga M; Mpoyi Muamba Nzambi D; Mayala Malu T; Kapongo Tshilumbwa S; Botalema Bolengi F; Nkieri Matsho M; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
Lancet Glob Health; 2021 Jul; 9(7):e999-e1008. PubMed ID: 34143998
[TBL] [Abstract][Full Text] [Related]
6. [Follow - up prognostic study on two imported patients with human African trypanosomiasis].
Li YY; Chen XL; Liu Q; Wang XY; Chen MX; Liu Q
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Jun; 33(3):293-296. PubMed ID: 34286532
[TBL] [Abstract][Full Text] [Related]
7. Human African trypanosomiasis caused by Trypanosoma brucei gambiense: The first case report in China.
Chen N; Jin K; Xu J; Zhang J; Weng Y
Int J Infect Dis; 2019 Feb; 79():34-36. PubMed ID: 30423460
[TBL] [Abstract][Full Text] [Related]
8. The phenomenon of treatment failures in Human African Trypanosomiasis.
Brun R; Schumacher R; Schmid C; Kunz C; Burri C
Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial.
Betu Kumeso VK; Kalonji WM; Rembry S; Valverde Mordt O; Ngolo Tete D; Prêtre A; Delhomme S; Ilunga Wa Kyhi M; Camara M; Catusse J; Schneitter S; Nusbaumer M; Mwamba Miaka E; Mahenzi Mbembo H; Makaya Mayawula J; Layba Camara M; Akwaso Massa F; Kaninda Badibabi L; Kasongo Bonama A; Kavunga Lukula P; Mutanda Kalonji S; Mariero Philemon P; Mokilifi Nganyonyi R; Embana Mankiara H; Asuka Akongo Nguba A; Kobo Muanza V; Mulenge Nasandhel E; Fifi Nzeza Bambuwu A; Scherrer B; Strub-Wourgaft N; Tarral A
Lancet Infect Dis; 2023 Apr; 23(4):463-470. PubMed ID: 36460027
[TBL] [Abstract][Full Text] [Related]
10. Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis.
Lejon V; Roger I; Mumba Ngoyi D; Menten J; Robays J; N'siesi FX; Bisser S; Boelaert M; Büscher P
Clin Infect Dis; 2008 Jul; 47(1):15-22. PubMed ID: 18494605
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging findings in human African trypanosomiasis: a four-year follow-up study in a patient and review of the literature.
Kager PA; Schipper HG; Stam J; Majoie CB
Am J Trop Med Hyg; 2009 Jun; 80(6):947-52. PubMed ID: 19478256
[TBL] [Abstract][Full Text] [Related]
12. Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects.
Bonnet J; Garcia C; Leger T; Couquet MP; Vignoles P; Vatunga G; Ndung'u J; Boudot C; Bisser S; Courtioux B
J Proteomics; 2019 Mar; 196():150-161. PubMed ID: 30414516
[TBL] [Abstract][Full Text] [Related]
13. The separation of trypanosomes from blood by anion exchange chromatography: From Sheila Lanham's discovery 50 years ago to a gold standard for sleeping sickness diagnosis.
Lejon V; Büscher P; Nzoumbou-Boko R; Bossard G; Jamonneau V; Bucheton B; Truc P; Lemesre JL; Solano P; Vincendeau P
PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007051. PubMed ID: 30817751
[TBL] [Abstract][Full Text] [Related]
14. Human African trypanosomiasis in non-endemic countries.
Sudarshi D; Brown M
Clin Med (Lond); 2015 Feb; 15(1):70-3. PubMed ID: 25650203
[TBL] [Abstract][Full Text] [Related]
15. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda.
Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC
Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206
[TBL] [Abstract][Full Text] [Related]
16. First evidence that parasite infecting apparent aparasitemic serological suspects in human African trypanosomiasis are Trypanosoma brucei gambiense and are similar to those found in patients.
Kaboré J; Koffi M; Bucheton B; MacLeod A; Duffy C; Ilboudo H; Camara M; De Meeûs T; Belem AM; Jamonneau V
Infect Genet Evol; 2011 Aug; 11(6):1250-5. PubMed ID: 21530681
[TBL] [Abstract][Full Text] [Related]
17. Delivery of antihuman African trypanosomiasis drugs across the blood-brain and blood-CSF barriers.
Sekhar GN; Watson CP; Fidanboylu M; Sanderson L; Thomas SA
Adv Pharmacol; 2014; 71():245-75. PubMed ID: 25307219
[TBL] [Abstract][Full Text] [Related]
18. Unusual MRI Findings in African
Boukobza M; Lariven S; Houzé S; Laissy JP
Am J Trop Med Hyg; 2020 Jan; 102(1):5-6. PubMed ID: 31971136
[No Abstract] [Full Text] [Related]
19. Polysomnography as a diagnosis and post-treatment follow-up tool in human African trypanosomiasis: a case study in an infant.
Mpandzou G; Cespuglio R; Ngampo S; Bandzouzi B; Bouteille B; Vincendeau P; Buguet A
J Neurol Sci; 2011 Jun; 305(1-2):112-5. PubMed ID: 21470639
[TBL] [Abstract][Full Text] [Related]
20. Identification of different trypanosome species in the mid-guts of tsetse flies of the Malanga (Kimpese) sleeping sickness focus of the Democratic Republic of Congo.
Simo G; Silatsa B; Flobert N; Lutumba P; Mansinsa P; Madinga J; Manzambi E; De Deken R; Asonganyi T
Parasit Vectors; 2012 Sep; 5():201. PubMed ID: 22992486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
